Get my own profile
Public access
View all35 articles
2 articles
available
not available
Based on funding mandates
Co-authors
- Amod SarnaikAssociate Professor of Cutaneous Oncology and ImmunologyVerified email at moffitt.org
- Jonathan ZagerDirector of Regional Therapies Moffitt Cancer CenterVerified email at moffitt.org
- Frederick L. LockeChair, Department of Blood and Marrow Transplant and Cellular ImmunotherapyVerified email at moffitt.org
- Arash NaghaviH. Lee Moffitt Cancer Center and Research InstituteVerified email at moffitt.org
- Matthew S BeattyMoffitt Cancer CenterVerified email at moffitt.org
- Marco DavilaTransplantation and Cellular Therapy, Roswell Park Comprehensive Cancer CenterVerified email at roswellpark.org
- Andrew BrohlMoffitt Cancer CenterVerified email at moffitt.org
- Jacob G. Scott (he/him)Associate Professor and Staff Physician-Scientist, Translational Hematology and Oncology ResearchVerified email at ccf.org
- Emmanuel ZervosProfessor of Surgery East Carolina UniversityVerified email at ecu.edu
- Kamran AhmedDepartment of Radiation Oncology, H. Lee Moffitt Cancer Center & Research InstituteVerified email at moffitt.org
- Jose M PimientoGI Oncology, Moffitt Cancer CenterVerified email at moffitt.org
- Alessandro GronchiChair Sarcoma Service, Dpt. of Surgey, Fondazione IRCCS Istituto Nazionale dei Tumori - Milan - ItalyVerified email at istitutotumori.mi.it
- Jeffrey FarmaFox Chase Cancer CenterVerified email at fccc.edu
- John F ThompsonMelanoma Institute AustraliaVerified email at melanoma.org.au
- Andriy MarusykMoffitt Cancer CenterVerified email at moffitt.org
- Krithika N kodumudi, M.Sc.,Ph.D. MBAAssociate Director, Iovance Biotherapeutics
Follow
John E. Mullinax, M.D.
Surgical Oncologist, Sarcoma Department, H. Lee Moffitt Cancer Center
Verified email at moffitt.org - Homepage